O

Oculis Holding AG
D

OCS

21.520
USD
0.53
(2.53%)
مغلق
حجم التداول
1,782
الربح لكل سهم
-3
العائد الربحي
-
P/E
-7
حجم السوق
1,126,265,534
المقالات

العنوان: Oculis Holding AG

القطاع: Healthcare
الصناعة: Biotechnology
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.